Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals (HEPA) Financial Statements


Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.511; its P/E ratio is -0.20; Hepion Pharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -14.08M$ -13.26M$ -10.12M$ -8.55M$ -19.91M
EBITDA$ -14.06M$ -13.24M$ -10.11M$ -8.53M$ -19.89M
Net Income Common Stockholders$ -14.08M$ -13.26M$ -9.96M$ -8.55M$ -19.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.52M$ 42.99M$ 51.19M$ 59.15M$ 71.71M
Total Assets$ 36.50M$ 49.50M$ 60.24M$ 69.70M$ 83.57M
Total Debt$ 0.00$ 0.00$ 53.61K$ 105.58K$ 176.86K
Net Debt$ -30.52M$ -42.99M$ -51.14M$ -59.04M$ -71.53M
Total Liabilities$ 10.13M$ 12.34M$ 10.39M$ 10.44M$ 16.25M
Stockholders Equity$ 26.37M$ 37.15M$ 49.86M$ 59.26M$ 67.32M
Cash Flow-
Free Cash Flow$ -12.52M$ -8.26M$ -4.82M$ -12.53M$ -7.50M
Operating Cash Flow$ -12.50M$ -8.26M$ -4.80M$ -12.53M$ -7.50M
Investing Cash Flow$ -16.54K$ 48.43K$ -16.34K$ 0.00$ 2.27K
Financing Cash Flow--$ -3.14M$ 0.00$ 0.00
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis